NCT00964028
- Conditions
- Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +23 more
- Locations
-
- GSK Investigational Site Wuzhou, Guangxi, China
Clinical trial condition
Haemophilus Influenzae Type b
Explore clinical trials studying Haemophilus Influenzae Type b. Study availability and eligibility vary by location and protocol.
84 public trials
0 recruiting studies
Haemophilus Influenzae Type b trial results
NCT00871338
- Conditions
- Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +5 more
- Locations
-
- GSK Investigational Site Ely, Cambridgeshire, United Kingdom
- GSK Investigational Site Southampton, Hampshire, United Kingdom
- GSK Investigational Site Oxford, Oxfordshire, United Kingdom
- GSK Investigational Site Bristol, United Kingdom
NCT00891176
- Conditions
- Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +5 more
- Locations
-
- GSK Investigational Site Bad Saulgau, Baden-Wurttemberg, Germany
- GSK Investigational Site Bretten, Baden-Wurttemberg, Germany
- GSK Investigational Site Ettenheim, Baden-Wurttemberg, Germany
- GSK Investigational Site Karlsruhe, Baden-Wurttemberg, Germany
NCT00473668
- Conditions
- Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +25 more
- Locations
-
- GSK Investigational Site Bangalore, India
- GSK Investigational Site Kolkotta, India
- GSK Investigational Site Varanasi, India
NCT00359983
- Conditions
- Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +5 more
- Locations
-
- GSK Investigational Site Little Rock, Arkansas, United States
- GSK Investigational Site Fountain Valley, California, United States
- GSK Investigational Site Norwich, Connecticut, United States
- GSK Investigational Site Marietta, Georgia, United States
NCT00345579
- Conditions
- Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +5 more
- Locations
-
- GSK Investigational Site Birmingham, Alabama, United States
- GSK Investigational Site Birmingham, Alabama, United States
- GSK Investigational Site Benton, Arkansas, United States
- GSK Investigational Site Fayetteville, Arkansas, United States
NCT00345683
- Conditions
- Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +5 more
- Locations
-
- GSK Investigational Site Birmingham, Alabama, United States
- GSK Investigational Site Birmingham, Alabama, United States
- GSK Investigational Site Benton, Arkansas, United States
- GSK Investigational Site Jonesboro, Arkansas, United States
NCT00376779
- Conditions
- Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +32 more
- Locations
-
- GSK Investigational Site Jarvenpaa, Finland
- GSK Investigational Site Oulu, Finland
- GSK Investigational Site Pori, Finland
- GSK Investigational Site Tampere, Finland
NCT00322335
- Conditions
- Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +5 more
- Locations
-
- GSK Investigational Site Almería, Spain
- GSK Investigational Site Burgos, Spain
- GSK Investigational Site Getafe/Madrid, Spain
- GSK Investigational Site Girona, Spain
NCT00379977
- Conditions
- Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +11 more
- Locations
-
- GSK Investigational Site Nanning, Guangxi, China